COMMUNIQUÉS West-GlobeNewswire

Eidos Therapeutics Announces Publication of AG10 Molecular Design in Journal of Medicinal Chemistry

23/08/2018 - 14:00

SAN FRANCISCO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced publication of the design and preclinical characterization of its lead product candidate, AG10, in the [...]

Tetra Bio-Pharma Targets Rare Cancers in the United States

23/08/2018 - 14:00

Tetra submits multiple cannabinoid applications to the FDA OTTAWA, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or “ TBP ”), today announced the submission of multiple applications for Orphan Drug [...]

CTD Holdings’ Trappsol® Cyclo™ Featured in Television Program on Niemann-Pick Disease Type C

23/08/2018 - 14:00

ALACHUA, Fla., Aug. 23, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]

Inovalon to Present at the Citi 2018 Global Technology Conference

23/08/2018 - 13:55

BOWIE, Md., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, MD, [...]

Novelion Therapeutics Announces Next Phase of Operational Improvements

23/08/2018 - 13:43

Once fully implemented, plans expected to reduce annual costs by approximately $35 million VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical [...]

SciCann Therapeutics reports positive pre-clinical results for proprietary CBD combination product

23/08/2018 - 13:30

TORONTO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- SciCann Therapeutics Inc reports today positive results of a pre-clinical efficacy study with its proprietary “Steady Stomach” CBD combination product for Inflammatory Bowel [...]

IMV Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference

23/08/2018 - 13:05

HALIFAX, Nova Scotia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Chief Executive Officer Frederic Ors and Chief Financial [...]

Karmanos Cancer Institute presents 25th Annual Partners Night Friday, Sept. 21, at historic Michigan Building Theatre

23/08/2018 - 13:05

Honoring Jack D. Sobel, M.D.; Celebrating Partners silver anniversary of supporting Karmanos’ cutting-edge cancer research DETROIT, Aug. 23, 2018 (GLOBE NEWSWIRE) -- On Friday, Sept. 21, the Barbara Ann Karmanos Cancer [...]

Protalix BioTherapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

23/08/2018 - 13:00

CARMIEL, Israel, Aug. 23, 2018 (GLOBE NEWSWIRE) -- GlobeNewswire /Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant [...]

Emerald Health Therapeutics Announces Amendment to Pure Sunfarms’ Cultivation License, Substantially Expanding Cannabis Production Area to Approximately 420,000 Square Feet

23/08/2018 - 13:00

VICTORIA, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) and Village Farms International, Inc. (TSX:VFF) (OTC: VFFIF) today announced that their [...]

Innovate Biopharmaceuticals Enters into an Agreement with Amarex Clinical Research for Data Management and Biostatistics for Phase 3 Celiac Disease Trial

23/08/2018 - 13:00

RALEIGH, N.C., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases [...]

Emblem Corp. Advances Funding for Natura Naturals Production

23/08/2018 - 12:30

TORONTO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) (“ Emblem ” or the “ Company ”) has established a working capital advance (the “ Advance ”) for Natura Naturals Holdings Inc. (“ Natura [...]

PCI Biotech: Invitation to first half year 2018 presentation

23/08/2018 - 12:23

Oslo, 23 August 2018 - PCI Biotech invites to a presentation of the company's second quarter and first half year 2018 report on Thursday 30 August 2018 at Oslo Cancer Cluster Innovation Park. Time: Thursday August 30, [...]

Acarix presenting the CADScor®System at ESC in Munich: A revolutionary technology for early and rapid rule out of Coronary Artery Disease

23/08/2018 - 12:16

Press release Malmö, Sweden August 23, 2018 Acarix presenting the CADScor®System at ESC in Munich: A revolutionary technology for early and rapid rule out of Coronary Artery Disease Visit us at booth D500 Exhibition [...]

Adherium and Vitalus Health Launch Commercial Program to Support Patients with Asthma and COPD

23/08/2018 - 12:00

SAN MATEO, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR) a digital health platform focused on improving medication adherence and patient outcomes, and Vitalus Health, a leading provider of comprehensive [...]

Major shareholding announcement

23/08/2018 - 08:05

Company announcement 23 August 2018 Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to have received a major [...]

Notice convening an Extraordinary General Meeting of NeuroSearch A/S

23/08/2018 - 08:00

Company announcement 23 August 2018 Pursuant to Articles 8 and 10 of the Articles of Association, notice is hereby given of an Extraordinary General Meeting to be held on 14 September 2018, at 11 a.m. at Kromann Reumert [...]

Shire plc: Rule 2.9 Announcement

23/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 August 2018 [...]

Ambu A/S: Interim report Q3 2017/18

23/08/2018 - 07:59

Ambu reports organic growth of 17% in Q3 and raises its outlook for this year's EBIT margin by 1 percentage point. Moreover, the target for sales of endoscopes is increased to 550,000 units. "Our business is moving [...]